Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The New England Journal of Medicine
|
November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
G L Davis, L A Balart, E R Schiff, et al.
Clinical Therapeutics
|
March 1, 1994
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile
G L Davis, L A Balart, E R Schiff, et al.
The American Journal of Gastroenterology
|
April 24, 2001
Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone
A D Min, J L Jones, S Esposito, et al.
Journal of Viral Hepatitis
|
December 10, 2016
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin
S Alqahtani, R Ozaras, V Isakov, et al.
Alimentary Pharmacology & Therapeutics
|
November 29, 2017
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3
Z M Younossi, M Stepanova, I M Jacobson, et al.
Journal of Viral Hepatitis
|
November 4, 2014
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies
M P Manns, M W Fried, S Zeuzem, et al.
The New England Journal of Medicine
|
August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
R P Perrillo, E R Schiff, G L Davis, et al.
Journal of Viral Hepatitis
|
October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
N H Afdhal, S Zeuzem, R T Schooley, et al.
Journal of Viral Hepatitis
|
August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
S Pianko, S Zeuzem, W-L Chuang, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G R Foster, S Zeuzem, S Pianko, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The New England Journal of Medicine
|
November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
G L Davis, L A Balart, E R Schiff, et al.
Clinical Therapeutics
|
March 1, 1994
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile
G L Davis, L A Balart, E R Schiff, et al.
The American Journal of Gastroenterology
|
April 24, 2001
Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone
A D Min, J L Jones, S Esposito, et al.
Journal of Viral Hepatitis
|
December 10, 2016
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin
S Alqahtani, R Ozaras, V Isakov, et al.
Alimentary Pharmacology & Therapeutics
|
November 29, 2017
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3
Z M Younossi, M Stepanova, I M Jacobson, et al.
Journal of Viral Hepatitis
|
November 4, 2014
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies
M P Manns, M W Fried, S Zeuzem, et al.
The New England Journal of Medicine
|
August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
R P Perrillo, E R Schiff, G L Davis, et al.
Journal of Viral Hepatitis
|
October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
N H Afdhal, S Zeuzem, R T Schooley, et al.
Journal of Viral Hepatitis
|
August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
S Pianko, S Zeuzem, W-L Chuang, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G R Foster, S Zeuzem, S Pianko, et al.
Page
of 5